Drug Research
AtomVie Builds Radiopharmaceutical CDMO Facility
AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will...
Drug Research
Novo Nordisk to Expand R&D Presence in Greater Boston Area
Novo Nordisk plans to expand its R&D presence in the greater Boston area, creating one of its largest R&D hubs outside of Denmark. The new...
Drug Research
Actylis Opens API Manufacturing Facility
Actylis, a global manufacturer of raw materials and performance ingredients for the life sciences and specialty chemicals markets, has opened a new 30,000 square foot...
Drug Research
AtomVie Builds Radiopharmaceutical CDMO Facility
AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will...
Clinical Trials
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal with...
Drug Research
Radiopharm Theranostics Partners With Next Generation Preclinical Platform for Therapeutic Radiopharmaceuticals
Radiopharm Theranostics , a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that through its wholly owned subsidiary, Radiopharm...
News
What Is The Basic Principle Of ELISA?
Some consider the enzyme-linked immunosorbent assay (ELISA) the gold standard for analytical techniques. In the field of biochemistry and immunology, researchers use it for detecting...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.